The pyrimido-pyrimidine derivatives RA 233 and RX-RA 85 affect growth and cytoskeletal organization ofrat mammary adenocarcinoma cells
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9) , 1269-1275
- https://doi.org/10.1016/0277-5379(87)90107-6
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Antiplatelet pyrimido-pyrimidines and metastasisCancer Treatment Reviews, 1985
- Enhancement of the Immune Response to Sheep Erythrocytes in Mice by Phosphodiesterase-Inhibiting Dipyridamole DerivativesJournal of Immunopharmacology, 1984
- Effect of Microtubule Inhibitors on Invasion and on Related Activities of Tumor CellsPublished by Elsevier ,1984
- Antitumour effect of RA 233 alone and combined with radiotherapyClinical & Experimental Metastasis, 1983
- The effect of 2,6-bis(diethanolamino)-4-piperidinopyrimido [5,4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanomaCancer Letters, 1982
- Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factorCell, 1981
- The regulatory subunit of adenylate cyclase interacts with cytoskeletal componentsNature, 1981
- Redistribution of myosin during morphological reversion of Chinese hamster ovary cells induced by db-cAMPExperimental Cell Research, 1980
- Microtubules in Cultured Cells; Indirect Immunofluorescent Staining with Tubulin AntibodyPublished by Elsevier ,1980
- Transmembrane control of the receptors on normal and tumor cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1976